Delivery Order SPE2DB24D8002-SPE2DB25FJMNV
Award Date
10/21/24
Potential Completion Date
10/22/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency's (DLA) Troop Support Medical division. The $4,700.70 firm fixed-price delivery order is for the provision of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is associated with Dakota Drug, Inc.'s existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support Medical's ECAT Generation V...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,138.04 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription medication. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the agency's ECAT Generation V Program. This single-award IDC allows the company to provide a...
This federal contract award, with a ceiling value of $12,260.41, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order (SPE2DB24FKYUA) under Dakota Drug's existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC, which is part of the DLA Troop Support Medical's ECAT Generation V...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $11,250.93 and a performance period through January 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,221.90 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription anticoagulant medication. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support...
This federal contract award, valued at $5,011.95, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $1,484.40 and a period of performance through February 28, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This contract, part of the DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract, with a ceiling value of $2,948.32, is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of October 17, 2023. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product, with a ceiling value of $1,353.12 and a period of performance through November 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00, which allows the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $11,147.30, is for the delivery of Eliquis 5 mg tablets. This is a firm fixed price delivery order contract, with an ultimate completion date of October 27, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...